33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of durvalumab in combination with tremelimumab in patients with advanced gastric cancer with elevated tumor interferon-gamma gene signature
    Meeting Abstract

    Ku, G.; Lee, J.; Lenz, H. J.; Chee, C. E.; Omori, T.; Lee, K. W.; Chao, Y.; Catenacci, D.; Gibson, M.; Cohen, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Preliminary results of PROCLAIM-CX-2009, a first-in-human, dose-finding study of the Probody drug conjugate CX-2009 in patients with advanced solid tumors
    Meeting Abstract

    Meric-Bernstam, F.; Boni, V.; Spira, A. I.; Sanborn, R. E.; Arkenau, H. T.; Sweis, R.; Burris, H.; Li, R.; Yalamanchili, S.; Will, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • MYB mimic peptides targeting human and murine MYB-NFIB positive tumor cells
    Meeting Abstract

    Jiang, Y.; Forbes, L.; Li, J.; Freeberg, S.; Cao, C.; Zajac-Kaye, M.; Licht, J.; Kentsis, A.; Kaye, F.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs)
    Meeting Abstract

    Janku, F.; Heinrich, M.; Chi, P.; Razak, A. A.; von Mehren, M.; Gordon, M.; Ganjoo, K.; Trent, J.; Jones, R. L.; Gelderblom, H.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Olaparib in patients (pts) with previously treated, homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD)-positive advanced cancer: Phase II LYNK-002 study
    Meeting Abstract

    Hyman, D.; Hendifar, A.; Chung, H. C.; Maio, M.; Leary, A.; Spanggaard, I.; Rhee, J.; Marton, M.; Chen, M.; Krishnan, S.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Genomic analyses and immunotherapy in advanced melanoma
    Meeting Abstract

    Hodi, F. S.; Wolchok, J. D.; Schadendorf, D.; Larkin, J.; Qian, M.; Saci, A.; Young, T. C.; Srinivasan, S.; Chang, H.; Wind-Rotolo, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi)
    Meeting Abstract

    Hyman, D.; Kummar, S.; Farago, A.; Geoerger, B.; Mau-Sorensen, M.; Taylor, M.; Garralda, E.; Nagasubramanian, R.; Natheson, M.; Song, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Implantable nanosensor for non-invasive ovarian cancer biomarker detection with wearable interface
    Meeting Abstract

    Heller, D. A.; Williams, R. M.; Levine, D. A.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Long non-coding RNA NEAT1 promotes lung metastasis of soft tissue sarcoma by regulating RNA splicing pathways
    Meeting Abstract

    Huang, J.; Xu, E.; Sachdeva, M.; Robinson, T.; Qin, X.; Zhang, D.; Owzar, K.; Gokgoz, N.; Seto, A.; Andrulis, I.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save